Indication
Skin and skin structure Enterobacter infection
Skin and skin structure *Enterobacter* infection refers to a localized bacterial infection of the cutaneous and subcutaneous tissues—such as cellulitis, cutaneous abscesses, or surgical wound infections—caused by species of the Gram-negative bacillus genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex. Read more about Skin and skin structure Enterobacter infection
251 drugs 106 manufacturers
Drugs that treat it
Common Skin and skin structure Enterobacter infection therapies.
GENTAMICIN SULFATE
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
CIPROFLOXACIN HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSkin and skin structure *Enterobacter* infection refers to a localized bacterial infection of the cutaneous and subcutaneous tissues—such as cellulitis, cutaneous abscesses, or surgical wound infections—caused by species of the Gram-negative bacillus genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex.
The condition predominantly affects hospitalized patients, surgical patients, and individuals who are immunocompromised or have disrupted integumentary barriers, such as surgical incisions, burns, chronic ulcers, or indwelling catheters.
Pathophysiologically, these opportunistic pathogens invade dermal and deeper structures through compromised epithelial defenses, producing clinical manifestations of localized erythema, warmth, edema, pain, and purulent exudate.
A defining clinical feature is the frequent expression of inducible AmpC beta-lactamases and multidrug resistance, which can complicate therapeutic eradication and predispose patients to invasive, deeper soft-tissue spread or bacteremia.
- nih.gov
Skin and skin structure *Enterobacter* infection refers to a localized bacterial infection of the cutaneous and subcutaneous tissues—such as cellulitis, cutaneous abscesses, or surgical wound infections—caused by species of the Gram-negative bacillus genus *Enterobacter*, most commonly members of the *Enterobacter cloacae* complex A defining clinical feature is the frequent expression of inducible AmpC beta-lactamases and multidrug resistance, which can complicate therapeutic eradication and pre...
- mdsearchlight.com
The condition predominantly affects hospitalized patients, surgical patients, and individuals who are immunocompromised or have disrupted integumentary barriers, such as surgical incisions, burns, chronic ulcers, or indwelling catheters
- marshall.edu
The condition predominantly affects hospitalized patients, surgical patients, and individuals who are immunocompromised or have disrupted integumentary barriers, such as surgical incisions, burns, chronic ulcers, or indwelling catheters Pathophysiologically, these opportunistic pathogens invade dermal and deeper structures through compromised epithelial defenses, producing clinical manifestations of localized erythema, warmth, edema, pain, and purulent exudate
- researchgate.net
The condition predominantly affects hospitalized patients, surgical patients, and individuals who are immunocompromised or have disrupted integumentary barriers, such as surgical incisions, burns, chronic ulcers, or indwelling catheters A defining clinical feature is the frequent expression of inducible AmpC beta-lactamases and multidrug resistance, which can complicate therapeutic eradication and predispose patients to invasive, deeper soft-tissue spread or bacteremia
- britannica.com
A defining clinical feature is the frequent expression of inducible AmpC beta-lactamases and multidrug resistance, which can complicate therapeutic eradication and predispose patients to invasive, deeper soft-tissue spread or bacteremia
Personalize your experience
Follow Skin and skin structure Enterobacter infection and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.